Tenet Healthcare has completed a transaction to fully reclaim Conifer Health Solutions, aiming to supercharge the unit's technology and service expansion. The move consolidates a key revenue platform as Tenet rides a multi-year stock surge.
Cisco Systems' stock is gaining momentum, fueled by surging demand from hyperscalers building AI data centers. The networking giant's raised guidance and record revenue have triggered a wave of analyst upgrades, positioning it as a key beneficiary of the AI infrastructure build-out.
Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.
AbbVie's $2.1 billion acquisition of Capstan Therapeutics signals a strategic pivot towards next-generation immunology treatments. The move aims to secure future revenue streams as the company navigates the post-Humira era, with analysts highlighting the transformative potential of its in vivo CAR-T platform.
As AI infrastructure spending accelerates, Arista Networks (ANET) is drawing investor attention with its debt-free balance sheet and critical role in cloud networking. Despite premium valuations, bulls argue its financial fortress and recurring software revenue justify the price, with a $163 price target signaling further upside.
Stride, Inc., a leading provider of K-12 online education, has seen its stock price pressured by temporary operational challenges. However, a closer look reveals a fundamentally sound business trading at a significant discount to its historical valuation, with a robust recurring revenue model and a substantial share buyback program underway.
Liberty Global, Europe's cable and mobile giant, has signed a five-year strategic partnership with Google Cloud to integrate Gemini AI and cloud tools across its operations, aiming to enhance TV platforms, automate services, and explore new revenue streams.
DaVita Inc. reported Q4 2025 results in line with expectations, highlighting a milestone first profitable year for its Integrated Kidney Care unit. While revenue per treatment accelerated, the company continues to face pressure from elevated patient mortality and rising benefit costs. Executives provided 2026 guidance projecting mid-single-digit operating income growth and a sharp rise in EPS, buoyed by share buybacks and the stabilization of prior investment losses.
Rambus reported record annual revenue and earnings for fiscal 2025, fueled by strong DDR5 adoption and AI-driven data center growth. While a one-time supply chain issue is expected to pressure Q1 2026 product revenue, management expressed confidence in a swift recovery and sustained long-term momentum.
Palantir Technologies' fourth-quarter earnings reveal a seismic shift, with U.S. commercial revenue for its AI Platform soaring 137%. The data analytics firm posted its highest growth rate as a public company, powered by massive government contracts and enterprise adoption, while setting aggressive targets for the year ahead.
InterDigital has secured a new multi-year patent license agreement with LG Electronics, extending its royalty base into consumer electronics like digital TVs and display monitors, signaling a strategic diversification of its licensing revenue.
Investment firm Hussman Strategic Advisors has liquidated its entire stake in TG Therapeutics, a move that comes as the biotech's stock lags behind broader market gains despite reporting strong revenue growth for its flagship product.
As Palantir Technologies reports a massive surge in U.S. government revenue, CEO Alex Karp publicly defends the company's controversial surveillance platforms, insisting they contain safeguards against overreach. The defense comes amidst growing public and political scrutiny over its contracts with immigration enforcement agencies.
Palantir Technologies shatters expectations with Q4 results, reporting a 70% revenue surge and forecasting continued robust growth, as its AI platform becomes a central driver for U.S. commercial business.
NXP Semiconductors projects first-quarter revenue above analyst expectations, fueled by resilient automotive chip sales and signs of stabilization in the industrial sector, despite ongoing softness in communications infrastructure.
The data analytics firm's fourth-quarter results showcase a decisive shift, with U.S. commercial revenue soaring 137% and profitability silencing long-time skeptics, even as its premium valuation demands sustained execution.
Teradyne (TER) shares surged over 10% after the semiconductor test equipment leader posted Q4 revenue and profit that smashed analyst estimates, fueled by surging demand from AI chipmakers. The company's bullish guidance signals confidence in a sustained industry upcycle.
As Amazon prepares to release its Q4 earnings, analysts are eyeing accelerated AWS growth and robust advertising revenue as key drivers that could propel the stock higher, mirroring its October surge.
Opera Limited's stock soared nearly 17% following its announcement of deeper integration of Tether's USDT and gold-backed tokens into its MiniPay wallet, targeting underbanked regions. The rally was further bolstered by stronger-than-expected preliminary Q4 2025 revenue figures.
Despite a star-studded client list and explosive revenue growth, IonQ's towering valuation and the nascent state of quantum computing signal significant risk for investors eyeing the recent sell-off.
